Population survey of CCR5 Δ32, CCR5 m303, CCR2b 64I, and SDF1 3′A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups

被引:40
作者
Wang, FS
Hong, WG
Cao, YZ
Liu, MX
Jin, L
Hu, LP
Wang, Z
Feng, TJ
Hou, J
Zhang, B
Shi, M
Xu, DP
Lei, ZY
Wang, B
Liu, ZD
Ye, JJ
Peng, L
Qiu, Y
Winkler, C
机构
[1] Beijing Hosp Infect Dis, Beijing Inst Infect Dis, Div Biol Engn, Beijing, Peoples R China
[2] Natl Ctr AIDS Prevent & Control, Beijing, Peoples R China
[3] Inst Med Informat, Div Med Stat, Beijing, Peoples R China
[4] Hlth & Antiepidem Ctr Henan Province, Zhengzhou, Peoples R China
[5] Shenzhen Hlth & Antiepidem Stn, Shenzhen, Guangdong Prov, Peoples R China
[6] Hlth & Antiepidem Ctr Xin Jiang Autonomous Reg, Mulomuqi, Peoples R China
[7] Sci & Technol Inst Family Planning, Kunming, Yunnan Province, Peoples R China
[8] NCI, Basic Res Program, SAIC Frederick Inc, Frederick, MD 21701 USA
关键词
coreceptors; SDF-1; CCR2; CCR5; HIV-1; allele frequency;
D O I
10.1097/00126334-200302010-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of this study is to determine in indigenous Chinese ethnic groups the frequencies of the chemokine (SDFI 3'A) and chemokine receptors (CCR5 Delta32, CCR5 m303, and CCR2b 641) HIV-1/AIDS restriction alleles. The study includes two cohorts; the first comprised 3165 indigenous healthy subjects representing eight ethnic groups: Han (n = 1406), Uygur (n = 316), Mongolia (n = 134), Hui (n = 386), Tibetan (n = 330), Zhuang (n = 378), Dai (n = 101), and Jingbo (n = 114). The second cohort consisted of 330 HIV-1-infected (86 subjects infected by sexual transmission and 198 subjects infected by HIV-1-contaminated blood or by sharing injection equipment; the remaining 46 subjects said nothing about HIV-1 transmission) and 474 HIV-1-uninfected Han Chinese belonging to one of two HIV-1 high-risk groups: intravenous drug users (n = 215) and individuals with sexually transmitted diseases (n = 259). Genotypes for the four genes were obtained using PCR (CCR5 Delta32) or PCR-restriction fragment length polymorphism. Randomly selected amplified PCR products were further confirmed by direct DNA sequencing. The variant allele frequencies were determined to be 0% to 3.48% for CCR5 Delta32, 0% for CCR5 m303, 16.23% to 28.79% for CCR2b 641, and 17.70% to 27.76% for SDFI 3'A in Chinese healthy individuals from eight ethnic groups. These findings show that allele frequencies differ among the eight Chinese ethnic groups for CCR5 Delta32, CCR2b 641, and SDFI 3'A and that the CCR5 m303 and CCR5 Delta32 mutant alleles were absent or infrequent in Chinese, which may be helpful for studies of specific anti-HIV-1 vaccine trials and coreceptor inhibitor drug targets in Chinese populations. Furthermore, we observed no significant differences in allele or genotypic frequencies between HIV-1-infected and HIV-1-uninfected groups from the Han ethnic group. Our finding is the first reporting that there is likely no effect of the examined polymorphisms in our study on HIV-1 transmission in the Chinese Han population, However, the genetic effects of these and other AIDS-modifying polymorphisms on the pathogenesis and clinical outcome of HIV-1/AIDS diseases is under investigation in Chinese populations.
引用
收藏
页码:124 / 130
页数:7
相关论文
共 36 条
[21]   Global distribution of the CCR5 gene 32-basepair deletion [J].
Martinson, JJ ;
Chapman, NH ;
Rees, DC ;
Liu, YT ;
Clegg, JB .
NATURE GENETICS, 1997, 16 (01) :100-103
[22]   CCR5 promoter polymorphism and HIV-1 disease progression [J].
McDermott, DH ;
Zimmerman, PA ;
Guignard, F ;
Kleeberger, CA ;
Leitman, SF ;
Murphy, PM .
LANCET, 1998, 352 (9131) :866-870
[23]   The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression [J].
Michael, NL ;
Chang, G ;
Louie, LG ;
Mascola, JR ;
Dondero, D ;
Birx, DL ;
Sheppard, HW .
NATURE MEDICINE, 1997, 3 (03) :338-340
[24]   AIDS: A role for host genes [J].
O'Brien, SJ .
HOSPITAL PRACTICE, 1998, 33 (07) :53-+
[25]   Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy [J].
O'Brien, TR ;
McDermott, DH ;
Ioannidis, JPA ;
Carrington, M ;
Murphy, PM ;
Havlir, DV ;
Richman, DD .
AIDS, 2000, 14 (07) :821-826
[26]   Analysis of the CC chemokine receptor 5 m303 mutation in infants born to HIV-1-seropositive mothers [J].
Ometto, L ;
Bertorelle, R ;
Mainardi, M ;
Giurisato, M ;
Chieco-Bianchi, L ;
De Rossi, A .
AIDS, 1999, 13 (07) :871-872
[27]  
Paxton WA, 1998, AIDS RES HUM RETROV, V14, pS89
[28]  
QI XQ, 2002, SIN US C RES TRAIN A, P7
[29]   HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene [J].
Quillent, C ;
Oberlin, E ;
Braun, J ;
Rousset, D ;
Gonzalez-Canali, G ;
Métais, P ;
Montagnier, L ;
Virelizier, JL ;
Arenzana-Seisdedos, F ;
Beretta, A .
LANCET, 1998, 351 (9095) :14-18
[30]   Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression [J].
Smith, MW ;
Dean, M ;
Carrington, M ;
Winkler, C ;
Huttley, GA ;
Lomb, DA ;
Goedert, JJ ;
OBrien, TR ;
Jacobson, LP ;
Kaslow, R ;
Buchbinder, S ;
Vittinghoff, E ;
Vlahov, D ;
Hoots, K ;
Hilgartner, MW ;
OBrien, SJ .
SCIENCE, 1997, 277 (5328) :959-965